secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-09-24T23:59:59+00:00
Accession:  0001493152-24-037858
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics elects Alan Stewart as director, ratifies auditor at annual meeting
--------------------------------------------------------------------------------

- Quorum of 57.57% (4,641,839 shares) present at Sep 20, 2024 annual meeting.
- Alan Stewart elected Class I director with 2,055,631 votes for; 2,586,208 abstentions, no against.
- George Ng did not stand for re-election; Board reduced from 6 to 5 members, no vacancy.
- Ratification of Marcum LLP as auditor passed with 4,547,883 for, 36,790 against, 57,166 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224037858/0001493152-24-037858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224037858/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer